Cargando…
Mutation spectrum associated with metastasis of advanced cholangiocarcinoma
BACKGROUND: The mutations associated with metastasis in advanced-stage cholangiocarcinoma (CCA) have not been investigated. OBJECTIVE: To explore mutations in patients with advanced CCA and independent factors related to metastasis. METHODS: This retrospective study performed next-generation sequenc...
Autores principales: | Song, Hao, Huang, Yao, Jiang, Xiaoqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218467/ https://www.ncbi.nlm.nih.gov/pubmed/35726602 http://dx.doi.org/10.1177/03000605221102080 |
Ejemplares similares
-
Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma
por: Jung, Jang Han, et al.
Publicado: (2017) -
Continued gefitinib retreatment beyond progression in patients with
advanced non-small cell lung cancer harboring sensitive EGFR
mutations
por: Jiang, Xuhong, et al.
Publicado: (2020) -
Effect of hepatic artery resection and reconstruction on the prognosis of patients with advanced hilar cholangiocarcinoma
por: Li, Yuan-Ming, et al.
Publicado: (2022) -
High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Song, Jian-Ping, et al.
Publicado: (2022) -
Factors associated with 5-year survival of combined hepatocellular and cholangiocarcinoma
por: Sempokuya, Tomoki, et al.
Publicado: (2020)